首页> 外文期刊>World Journal of Gastroenterology >Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis
【24h】

Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis

机译:用成本效益分析对类癌​​进行闪烁扫描

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To evaluate the diagnostic sensitivity and accuracy and the cost-effectiveness of this technique in the detection of gastroenteropancreatic carcinoid tumors and their metastases in comparison with conventional imaging methods. METHODS: Somatostatin receptor scintigraphy (SRS) was performed in 24 patients with confirmed carcinoids and 7 under investigation. The results were compared with those of conventional imaging methods (chest X-ray, upper abdominal ultrasound, chest CT, upper and lower abdominal CT). Also a cost-effectiveness analysis was performed comparing the cost in Euro of several combinations of SRS with conventional imaging modalities. RESULTS: SRS visualized primary or metastatic sites in 71.0% of cases and 61.3% of conventional imagings. The diagnostic sensitivity of the method was higher in patients with suspected lesions (85.7% vs 57.1%). SRS was less sensitive in the detection of metastatic sites (78.9% vs 84.2%). The undetectable lesions by SRS metastatic sites were all in the liver. Between several imaging combinations, the combinations of chest X-ray/upper abdominal CT/SRS and chest CT/upper abdominal CT/SRS showed the highest sensitivity (88.75%) in terms of the number of detected lesions. The combinations of chest X-ray/upper abdominal US/SRS and chest CT/upper abdominal ultrasound /SRS yielded also a quite similar sensitivity (82%). Compared to the cost of the four sensitive combinations the combination of chest X-ray/upper abdominal ultrasound/SRS presented the lower cost, 1183.99 Euro vs 1251.75 Euro for chest CT/upper abdominal ultrasound/SRS, 1294.93 Euro for chest X/ray/upper abdominal CT/SRS and 1362.75 Euro for chest CT/upper abdominal CT/SRS. CONCLUSION: SRS imaging is a very sensitive method for the detection of gastroenteropancreatic carcinoids but is less sensitive than ultrasound and CT in the detection of liver metastases. Between several imaging combinations, the combination of chest X-ray/upper abdominal CT/SRS shows the highest sensitivity with a cost of 1294.93 Euro.
机译:目的:与常规成像方法相比,评价该技术在检测胃肠胰腺类癌及其转移中的诊断敏感性,准确性和成本效益。方法:对24例确诊类癌患者和7例接受调查的患者进行生长抑素受体闪烁显像(SRS)。将结果与常规成像方法(胸部X射线,上腹部超声,胸部CT,上下腹部CT)进行比较。还进行了成本效益分析,将几种SRS组合与常规成像方式的欧元成本进行了比较。结果:SRS在71.0%的病例和61.3%的常规影像学检查中可看到原发或转移部位。该方法的诊断敏感性在可疑病变患者中更高(85.7%对57.1%)。 SRS对转移部位的检测灵敏度较低(78.9%对84.2%)。 SRS转移部位无法检测到的病变全部在肝脏中。在几种影像学组合之间,就检测到的病变数量而言,胸部X线/上腹部CT / SRS和胸部CT /上腹部CT / SRS的组合显示出最高的灵敏度(88.75%)。胸部X光/上腹部US / SRS和胸部CT /上腹部超声/ SRS的组合也产生了非常相似的敏感性(82%)。与四种敏感组合的费用相比,胸部X射线/上腹部超声/ SRS的组合成本更低,分别为1183.99欧元和胸部CT /上腹部超声/ SRS的1251.75欧元,胸部X /射线/1294.93欧元上腹部CT / SRS和胸部CT /上腹部CT / SRS的费用为1362.75欧元。结论:SRS成像是一种检测胃肠道胰腺类癌的非常灵敏的方法,但是在检测肝转移方面不如超声和CT敏感。在几种成像组合之间,胸部X光/上腹部CT / SRS的组合显示出最高的灵敏度,其成本为1294.93欧元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号